A detailed history of Affinity Asset Advisors, LLC transactions in Geron Corp stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,500,000 shares of GERN stock, worth $5.99 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
1,500,000
Previous 1,500,000 -0.0%
Holding current value
$5.99 Million
Previous $6.36 Million 7.08%
% of portfolio
1.18%
Previous 0.87%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.1 - $5.09 $3.1 Million - $5.09 Million
-1,000,000 Reduced 40.0%
1,500,000 $6.36 Million
Q1 2024

May 14, 2024

BUY
$1.75 - $3.44 $4.38 Million - $8.6 Million
2,500,000 New
2,500,000 $8.25 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.